Table 1.
Demographics and Baseline Clinical Characteristics
| Suzetrigine N = 256 | |
|---|---|
| Age (years), mean (SD) | 43.9 (14.1) |
| Male, n (%) | 83 (32.4) |
| Age (years), mean (SD) | 44.0 (14.1) |
| Female, n (%) | 173 (67.6) |
| Age (years), mean (SD) | 43.9 (14.1) |
| Race, n (%) | |
| White | 214 (83.6) |
| Black or African American | 34 (13.3) |
| Asian | 3 (1.2) |
| American Indian or Alaska Native | 3 (1.2) |
| Native Hawaiian or other Pacific Islander | 1 (0.4) |
| Multiracial | 1 (0.4) |
| BMI (kg/m2), mean (SD) | 29.29 (4.91) |
| NPRS, mean (SD) | 6.7 (1.7) |
| VRS, n (%) | |
| Moderate | 191 (74.6) |
| Severe | 65 (25.4) |
| Surgical Status, n (%) | |
| Surgical | 222 (86.7) |
| Non-Surgical | 34 (13.3) |
Notes: Table includes participants who received at least one dose of suzetrigine.
Abbreviations: BMI, body mass index; N, number of participants in the analysis set; n, number of participants; NPRS, Numeric Pain Rating Scale; SD, standard deviation; VRS, Verbal Categorical Rating Scale.